Knight Therapeutics Inc. (GUD) — research page
CA · ca-cm-kg/TSX/GUD · as of 2026-11-06
Identity and listing
Knight Therapeutics Inc. is listed on the TSX under the ticker GUD. Its ISIN is CA4990531069 and its LEI is not on the record, because the ISIN is not in the GLEIF ISIN-to-LEI mapping file. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Knight Therapeutics Inc. | source · 2026-11-06 |
| exchange | TSX | source · 2026-11-06 |
| ticker | GUD | source · 2026-11-06 |
| ISIN | CA4990531069 | source · 2026-11-06 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | Life Sciences | source · 2026-11-06 |
| jurisdiction | Canada (federal, CBCA) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 13 filings across 9 filing days in the window 2025-11-06 to 2026-11-06. The filings comprise 9 newswire releases, 3 financial statements and 1 corporate action. The median gap between filing days is 12.5 days, against a TSX median of 16 days and a Life Sciences median of 17.5 days. The latest filing is dated 2026-11-05, is a financial statement, and is 1 day before the record date of 2026-11-06. The TSX median latency is 3.0 days and the Life Sciences median latency is 14 days. The Life Sciences median filing count over the window is 7.0 and the TSX median filing count is 0.0.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 13 | 12.5 | 1 |
| exchange median: TSX (2270 issuers) | 0 | 16 | 3 |
| sector median: Life Sciences (200 issuers) | 7 | 17.5 | 14 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | financial_statement | Knight Therapeutics Reports Third Quarter 2026 Results | |
| 2026-10-29 | financial_statement | Notice of Knight Therapeutics' Third Quarter 2026 Results | |
| 2026-10-06 | newswire_release | Knight Therapeutics Announces Regulatory Approval of | |
| 2026-10-06 | newswire_release | Knight Therapeutics Announces Launch of TAVALISSE® in | |
| 2026-09-29 | corporate_action | Knight Therapeutics Enters into Exclusive Distribution |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Ernst & Young LLP. Its location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is listed, not halted.
Orderability
Under rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, with the chapter as of 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200 and is determinable. The outcome for Paragraph (q) of the definition is signal ACM-200 and is determinable.
| client category | outcome |
|---|---|
| Paragraph (o) of the definition | ACM-200 |
| Paragraph (q) of the definition | ACM-200 |
rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The field has not been read, so no research houses named on the issuer's investor-relations page are recorded.
Open research
The field has not been read, so no openly published research notes are recorded.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.tsx.com/json/company-directory/search/tsx/^* (identity.exchange)
- 10.2
- https://www.marketscreener.com/quote/stock/KNIGHT-THERAPEUTICS-INC-15925497 (identity.isin)
- 10.3
- https://s203.q4cdn.com/535621653/files/doc_financials/2024/ar/Management-information-circular-English.pdf (identity.jurisdiction)
- 10.4
- https://www.tsx.com/en/resource/571 (identity.sector)
- 10.5
- https://mcp.ca-cm-kg.ai/events/TSX/GUD (the disclosure lines)
- 10.6
- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
- 10.7
- https://investors.knighttx.com/English/resources/investor-contacts/default.aspx (the auditor)
- 10.8
- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://mcp.ca-cm-kg.ai/record/TSX/GUD (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"CA4990531069"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:1148f3d930553e40.